Read + Share
Whitman ED, Totev TI, Jiang S, da Costa WL Jr, et al. Assessing the use of anti-PD1 monotherapy as adjuvant therapy and determinants of
treatment choice in stage III cutaneous melanoma in the US. BMC Cancer 2024;24:389.
PMID: 38539148
|
 |
|
Whitman ED, Totev TI, Jiang S, da Costa WL Jr, et al. Assessing the use of anti-PD1 monotherapy as adjuvant therapy and determinants of
treatment choice in stage III cutaneous melanoma in the US. BMC Cancer 2024;24:389.
PMID: 38539148
|
|
|
|